Quest PharmaTech, Inc. (QPT.V)
0.02
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Quest PharmaTech Shareholders Equity (Quarterly) : 26.43M for Jan. 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2026 | 26.43M |
| October 31, 2025 | 23.08M |
| July 31, 2025 | 21.91M |
| April 30, 2025 | 22.09M |
| January 31, 2025 | 21.40M |
| October 31, 2024 | 23.12M |
| July 31, 2024 | 23.01M |
| April 30, 2024 | 22.28M |
| January 31, 2024 | 23.15M |
| October 31, 2023 | 25.08M |
| July 31, 2023 | 25.84M |
| April 30, 2023 | 25.59M |
| January 31, 2023 | 83.25M |
| October 31, 2022 | 88.07M |
| July 31, 2022 | 88.97M |
| April 30, 2022 | 89.45M |
| January 31, 2022 | 90.41M |
| October 31, 2021 | 166.33M |
| July 31, 2021 | 175.36M |
| April 30, 2021 | 174.64M |
| January 31, 2021 | 175.22M |
| October 31, 2020 | 112.18M |
| July 31, 2020 | 108.39M |
| April 30, 2020 | 105.13M |
| January 31, 2020 | -15.34M |
| Date | Value |
|---|---|
| October 31, 2019 | -13.42M |
| July 31, 2019 | -12.20M |
| April 30, 2019 | -11.52M |
| January 31, 2019 | -10.27M |
| October 31, 2018 | -9.438M |
| July 31, 2018 | -9.040M |
| April 30, 2018 | -8.343M |
| January 31, 2018 | -7.381M |
| October 31, 2017 | 11.89M |
| July 31, 2017 | 13.33M |
| April 30, 2017 | 10.11M |
| January 31, 2017 | 11.02M |
| October 31, 2016 | 12.49M |
| July 31, 2016 | 13.55M |
| April 30, 2016 | -2.561M |
| January 31, 2016 | -2.324M |
| October 31, 2015 | -1.693M |
| July 31, 2015 | -3.482M |
| April 30, 2015 | -3.982M |
| January 31, 2015 | -3.734M |
| October 31, 2014 | -2.965M |
| July 31, 2014 | -3.109M |
| April 30, 2014 | -2.796M |
| January 31, 2014 | -2.413M |
| October 31, 2013 | -1.121M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Kane Biotech, Inc. | -1.418M |
| BriaCell Therapeutics Corp. | 32.75M |
| Vaxil Bio Ltd. | 1.258M |
| Waverley Pharma, Inc. | -2.725M |
| Goldcoast Resource Corp. | 0.6796M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.75M |
| Total Liabilities (Quarterly) | 1.329M |
| Debt to Equity Ratio | 0.0378 |
| Current Ratio | 0.0248 |